Adeel Memon
Neurology · Birmingham, ALNPI 1598147134
Payments from drug & device makers
Across 17 payments — averaging $195.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insightec,inc$2K
- Lundbeck LLC$651
- Medtronic$254
- Boston Scientific$134
- AbbVie$63
- Supernus Pharmaceuticals, Inc.$42
- plus $26 from 1 others
What the payments were for
- Speaking & faculty fees$65120%
- Travel & lodging$1,87757%
- Food & beverage$79124%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insightec,inc | 5 | $2,150 |
| Lundbeck LLC | 2 | $651 |
| Medtronic | 4 | $254 |
| Boston Scientific | 2 | $134 |
| AbbVie | 2 | $63 |
| Supernus Pharmaceuticals, Inc. | 1 | $42 |
| Acadia Pharmaceuticals Inc | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Exablate$2,044
- NORTHERA$651
- GENERAL DBS$111
How this compares
$3,320 in reported general payments places this provider in the 50th percentile of 255 neurology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 29 | $194,417 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 262 | $8,822 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 80 | $3,096 |
| Propranolol Hcl ErPropranolol Hcl | 53 | $2,074 |
| Primidone | 59 | $1,782 |
| AmantadineAmantadine Hcl | 11 | $1,563 |
| Tetrabenazine | 12 | $1,161 |
| Propranolol Hcl | 19 | $539 |
| Donepezil Hcl | 21 | $283 |
| Escitalopram Oxalate | 20 | $239 |
| Gabapentin | 20 | $212 |
| Topiramate | 12 | $80 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other neurology in Birmingham
- Emily RiserBirmingham$7.1M
- Louis NaborsBirmingham$3.2M
- Khurram BashirBirmingham$2.8M
- David GeldmacherBirmingham$2.6M
- Victor SungBirmingham$2M
- Mina LobbousBirmingham$1.8M
- Diane CounceBirmingham$1.4M
- Marissa Natelson LoveBirmingham$792K
- David StandaertBirmingham$787K
- Marissa DeanBirmingham$592K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.